Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5397_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
15
Добавлен:
15.09.2026
Размер:
15 Мб
Скачать
☆
34
https://t.me/med1917
product, the development of process analysis technology (PAT) has emerged as a method for strategically planning, evaluating, and controlling manufacturing. PAT involves the timely measurement (i.e., during processing) of crucial quality and performance attributes related to both raw and in process materials and processes (Zhang etal. 2020).
In PAT, the word “analysis” is widely understood to refer to combined chemical, physical, and biological properties (Ramakrishnan etal. 2020). Nonetheless, the majority of pharmaceutical manufacturing quality control methods concentrate on physicochemical property analysis. Since natural products are intricate mixtures, it is extremely difcult for existing chromatographic and spectroscopic methods that rely on the chemical approach to identify every component of these complicated mixtures due to their chemical complexity. Moreover, the absence of empirical sup­port for the correlation between the chemical information provided by the chemical approach and overall invivo activity raises concerns about the clinical safety and efcacy of medications. Chromatographic procedures, limited by their inability to detect certain substances, especially certain biologically active components and bio-pollutants, contribute to the insufciency of available data. The quality of syn­thetic medications and natural items has been regulated through the application of biotechnology. Biotechnological techniques offer the advantage of furnishing insights into the immediate bioactivity, clinical safety, and efcacy of biological products, notwithstanding their inability to furnish information pertaining to chemi­cal components.
G. Dey et al.
3.3 Monitoring ofProcess
3.3.1 Chemical andBiological Coupling
forPharmaceutical Process
Few bioassays now available can meet the three assay requirements of speed, sensi­tivity, and multiplexing. Given the multi-component and multi-target nature of natu­ral products, detection strategies with multiplexing capabilities are highly prized.
Consequently, scholars are exploring the integration of biological assays with chemical analysis. This amalgamation facilitates concurrent examinations of both biological and chemical aspects on a unied analytical platform, thereby decreasing instrument costs and variations. Recent developments in ambient ionization technol­ogy have made mass spectrometry (MS) a potentially inventive PAT tool in the pro­duction of natural products. Li and colleagues (Ramakrishnan etal. 2020) introduced an on- demand technique utilizing direct analysis in real-time mass spectrometry (DART-MS). This method assesses the biological activity of specic entities, namely thrombin and angiotensin-converting enzyme (ACE), employing a mass spectrome­try probe as the substrate for the enzymes. Each probe has a distinct peptide sequence and a high-ionization-efciency label made of 1-(2-pyrimidyl) piperazine. The
3 Application ofBiotechnology inPharmaceutical Manufacturing Control
https://t.me/med1917
methodology prociently achieved the concurrent evaluation of the chemical compo­sition and biological attributes of Danshen (Salvia miltiorrhiza) injection. The results from the detection process illustrated the capability of the platform to assess the qual­ity of the drug across various dimensions, all under continuous real-time monitoring.
35
3.3.2 Quality Control forPharmaceutical Process by Using
Biological Soft Sensing
Because natural goods are diverse, there is variation in the raw materials and pharma­ceutical products, which raises questions about the therapeutic consistency of these items. For this reason, multi-dimensional quality control is necessary to guarantee the security and effectiveness of these pharmaceutical items. In addition to being expensive, using various instruments for the quality analysis of various dimensions leads to differences between the equipment. A recent and well-liked technique in the monitoring industry is soft sensing. Thanks to this technology, it is possible to esti­mate a quality or activity in real time using a mathematical model and readily observ­able indications that are challenging to measure directly (Fraser et al. 2013). Consequently, soft sensing performs well when it comes to identifying quality indi­cators that are challenging to assess in industrial and pharmaceutical operations. Using the Shuxuening injection as an example, Zhong etal. (Li etal. 2019) employed a non-destructive method of simultaneously monitoring the injection’s physical char­acteristics, chemical makeup, and biological activity by combining articial intelli­gence (AI) with hyperspectral imaging (HSI) as a biological soft sensing technology. Drug component identication frequently necessitates the use of analytical tools like high-performance liquid chromatography (HPLC). Z-Gly- GlyArg-AMC acetate probe substrate and the DPPH-free radical scavenging assay are needed for antioxi­dant and anticoagulant actions. Image recognition methods are used to identify the injection’s chromaticity and visible particles. The ve quality indicators of total ginkgolides, total avonol, anticoagulant activity, antioxidant activity, and visible particles were predicted by the HSI-AI technique. As a result, the platform may be utilized to monitor several quality attributes during the production process of phar­maceuticals. Under non-destructive circumstances, biological soft sensing methods in conjunction with HSI can simultaneously acquire many quality aspects of a sample.
3.4 Intermediate Product Analysis
Variations in natural products and the shifting of operational parameters in each process unit can cause variations in intermediate quality between batches in the pharmaceutical process, which can impact the quality of the nished product. Thus, quality control must be applied to the intermediates generated during the process.
36
https://t.me/med1917
G. Dey et al.
3.4.1 Intermediate Product Analysis by Biological
andChemical Coupling
Uncertainty surrounds pharmaceutical items due to the variety of natural product sources and industrial settings. Every biological and chemical active ingredient that could have an impact on the potency and quality of medications is precisely and thoroughly identied. Shuxuening injection (SI) is primarily based on its antioxi­dant properties. To guarantee its quality, it is crucial to conduct both quantitative and qualitative evaluations of antioxidants in the pharmaceutical process. An online analytical approach called ABTSÍ (2,2-azinobis-(3-ethyl benzothiazoline-6- sulfonic acid))-CE was developed by Ma etal. (Li etal. 2019) to monitor different antioxi­dants during the injection preparation process. Initially, ABTSÍ was incorporated into the capillary and utilized for the concurrent identication and segregation of the primary antioxidants in the injection. The technique is a straightforward, depend­able, and efcient instrument for the quantitative assessment of medications, as demonstrated by the experimental results, which SI validated. Certain indicators are unable to thoroughly assess TCM compositions with several components, hence ignoring the chemical complexity and several mechanisms that contribute to their pharmacological action. Wang etal. (Zhu etal. 2020) suggested a method for evalu­ating the quality of Typha orientalis by combining metabolomics and chemometrics with bioactive chemical comprehensive indicators based on thrombin. This study offers suggestions for developing techniques to assess a drug’s chemical and bio­logical qualities at the same time. This study offers suggestions for developing tech­niques to assess a drug’s chemical and biological qualities at the same time (Table3.1) (Fig.3.3).
3.4.2 Biosensors fortheAnalysis ofIntermediate Products
Small, integrated analytical devices known as biosensors are made up of biological elements in close proximity to physical sensors, which translate biological processes into quantiable data. Through the utilization of biometric elements that transform data derived from the biological domain into chemical or physical signals, these sen­sors furnish precise quantitative or semi-quantitative analytical information (Zhu etal. 2020; Ma etal. 2018; Wang etal. 2020). In a research endeavor, the identica­tion of bromocriptine was accomplished utilizing a label-free biosensor founded on surface plasmon resonance (SPR) technology (Andryukov etal. 2021). To ensure the precision and dependability of the ndings, potential enzymes for the bromocriptine biosensor were rst evaluated using a competitive inhibition experiment and a pro­tein ligand docking simulation. Drug monitoring that is quick, real time, and label­free is possible with this enzyme SPR technique. The ndings demonstrated that different enzymes and SPR technology might be used to monitor different medica­tions. An alternative investigation proposed the utilization of hollow ber-based
3 Application ofBiotechnology inPharmaceutical Manufacturing Control
https://t.me/med1917
Table 3.1 Application of biotechnology in pharmaceutical manufacturing control
Category Technique Response Applications References Biosensor for
PAT
Protein chip for target enzyme
Biological chemical coupling technology
Biological soft sensing technology
HF-AS Lipase-binding
ligand
Enzyme-based SPR
TPE uorescent probe
Aptamer biosensor
FRET uorescent acceptor
PAD Hypoglycemic and
Dual channel microuidic chip
ABTS+ CE Major antioxidant
Metabolomics chemometrics
DART-MS enzyme
NIR machine learning
HIS-AI-CNN Physical chemical
Acceptable therapeutic monitoring
Monitor ACE activity
Rapid detection of pathogenic E. coli
Zearalenone and Partulin
xanthine oxidase inhibitory activity
Multiple biomarker assay
in injection Bioactive chemical
quality marker combination
Chemical component and biological activities
Chemical compounds and anti-inammatory activity
and biological properties
Lotus leaf extracts Li etal. (2019)
Bromocriptine Ma etal. (2018)
Tongmaiyangxin pill Wang etal.
(2020)
Licorice extracts Jabbari etal.
(2017)
Extracts of TCM Tao etal. (2013)
Mulberry, lotus, and salvia miltiorrhiza extracts
Qishen Yiqi pill Gong etal.
Shuxuening injection
Pollen of T.
orientalis
Danshen injection Li etal. (2017)
Chrysanthemum extracts
Shuxuening injection
Wang etal. (2014), Zhang etal. (2022), Zhao etal. (2018)
(2021)
Guo etal. (2018)
Guo etal. (2019)
Zhong etal. (2022)
Ding etal. (2016)
37
afnity selection for identifying inhibitors within a medicinal plant extract (Bhavadharini etal. 2022). The initial step involved the adsorption of swine pancreas lipase onto the polypropylene hollow ber surface to establish a resilient ligand­harvesting matrix. The known lipase was then used to optimize a number of binding capacity-related parameters, such as temperature, incubation duration, and enzyme concentration. Lotus leaf extracts containing lipase-binding ligands can be identied using the suggested technique. Tetraphenylethylene (TPE) is a common aggregation­induced emission-based uorophore with a variety of uses in cell imaging and bio­sensors. TPE-based uorescent probes were produced by Wang et al. (Vigneshvar etal. 2016) using two procedures. Two types of TPE were produced using normal
38
https://t.me/med1917
Fig. 3.3 Biotechnologies in pharmaceutical manufacturing process control and intermediate analysis
G. Dey et al.
solid-phase synthesis and the McMurray reaction: TPE with the carboxylate group and TPE-SDKP.This assay functions as a method for monitoring angiotensin-con­verting enzyme (ACE) activity and assessing the effectiveness of ACE inhibitors sourced from extracts. Aptamers, single-stranded oligonucleotide molecules chosen through ligand evolution using an exponential enrichment mechanism, present numerous benets, including notable specicity, robust stability, cost-effectiveness, ease of modication, and straightforward invitro production. They present a viable alternative to the expensive antibody-based Enzyme-Linked Immunosorbent Assay (ELISA) and can serve as an alternative recognition element in biosensors alongside antibodies. Various sensing platforms utilizing aptamers have been developed for the detection of pollutants and cytotoxins in both food and pharmaceutical contexts. Cytotoxin and other contaminants have a signicant negative impact on human health; hence their detection in the pharmaceutical process must be constantly moni­tored (Jabbari etal. 2017; Tao etal. 2013; Wang etal. 2014; Ahmadi etal. 2019; Caglayan and U¨stu¨ndag 2020; He etal. 2020; Jiang etal. 2020; Khan etal. 2018). In a recent study, patulin (PAT) and zearalenone (ZEN) were detected simultaneously by the use of uorescent acceptors. In this work, uorescent probes tagged FAM and CY3 on the aptamers of PAT and ZEN, respectively (Khan etal. 2020). Through pep stacking, both aptamers were adsorbed on the surface of graphene oxide (GO), caus­ing an energy transfer known as uorescence resonance between the uorophore and GO.As a result, our detection platform detects TCM samples with good selectivity and reliability. The harm that pathogenic E. coli does to human health is becoming more and more noticeable (Mahmoud et al. 2019). In a recent study, pathogenic E. coli was quickly identied using licorice extracts and an aptamer-based electro­chemical biosensor. E. coli was biotinylated after the sulfuration signal was initially detected in order to improve the interaction between the aptamer and the bacteria (Wu etal. 2018). When E. coli was present, a part of the biotinylated aptamer sepa­rated from the capture probe. Streptavidin-alkaline phosphatase was quantitatively bound by residual biotinylated aptamer probes. The outcomes demonstrated that bac­teria in TCM and related disciplines can be quickly detected using the biosensor that
3 Application ofBiotechnology inPharmaceutical Manufacturing Control
https://t.me/med1917
was designed. The benets of biosensors include excellent accuracy, quick analysis times, and strong specicity. The integration of computers and biosensors enables the automated collection and processing of data, leading to more accurate and scien­tically robust outcomes and the establishment of automated detection systems. To fully harness the potential of integrated detection systems, there is a growing trend toward simultaneous coupling of chip technology and sensors.
39
3.4.3 Protein Chips inIntermediate Product Analysis
Paper-based microarrays are paper-based analytical instruments that have seen tre­mendous development in the last few years (Xing etal. 2020; Zhang etal. 2019,
2022; Zhao etal. 2018). They are inexpensive, simple to use, and capable of carry-
ing out several chemical analyses. Furthermore, the high specic surface area of these paper devices makes it simple for molecules to bind and adsorb proteins. To lessen the pollution that experimental consumables produce, used paper devices can be burned. An excellent background signal for detecting colorimetric reactions is provided by the white paper. Paper-based microarrays are a type of analytical tool that have seen fast development in the last few years (Xing etal. 2020; Zhang etal.
2019, 2022; Zhao etal. 2018). They are inexpensive, simple to use, and capable of
carrying out several chemical analyses. Furthermore, the high specic surface area of these paper devices facilitates easy protein adsorption and binding by molecules. To lessen the pollution that experimental consumables produce, used paper devices can be burned. An excellent background signal for detecting colorimetric reactions is provided by the white paper. In order to build paper-based microarrays and use them to identify active ingredients in TCM extracts, Gong etal. (Wang etal. 2019). presented an efcient omics method. Using 3D printing (3DP), customized paper containing polycaprolactone and chitosan was created, and a-glucosidase was ren­dered immobile on it. Using a paper-based analytical apparatus, the method was applied to investigate the hypoglycemic biological activity of lotus and mulberry extracts (PAD) (Gu etal. 2011; He etal. 2015). Another researcher examined the xanthine oxidase inhibitory activity of S. miltiorrhiza extracts after immobilizing xanthine oxidase on a PAD69. Therefore, natural products, intermediates, and prep­arations can be quickly tested for quality using paper-based microarrays (Mitchell etal. 2015). Biomarkers have been utilized as evaluative indicators of pharmaceuti­cal quality, serving to appraise the biological attributes of formulations. A good biomarker should be clinically meaningful and should represent the drug’s mode of action. In one study, ACEs and thrombin were used as quality biomarkers in a chip­based approach to assess the bio-consistency of natural products. For bioassays, a dual channel microuidic chip was created (Ahmed etal. 2016), in which an enzy­matic reaction takes place in one channel after the creation of an enzyme complex in the other. In addition to providing an effective surface for immobilizing enzymes, magnetic beads also act as a dependable, robust base for improved on-chip mixing and transport. Drug quality (or potency) is indicated by enzyme activity. Several
40
https://t.me/med1917
batches of intermediates and preparations were evaluated in Qishen Yiqi Pills, and the ndings indicated that the bioassay outperformed chromatographic ngerprint­ing in terms of discriminatory power for aberrant samples.
G. Dey et al.
3.4.4 Intermediate Product Analysis Through Biological
Soft Sensing
Although the correlation between spectrum and activity has often been disregarded, a predominant focus of research has been on elucidating the interconnection between chromatography/mass spectrometry and the biological activity of natural products. Using near-infrared reectance spectroscopy (NIRS), chrysanthemum extracts’ anti-inammatory properties were discovered (Gong etal. 2021). NIRS was employed in this study together with information on anti-inammatory activity. Through the utilization of the backpropagation articial neural network, a sophisti­cated correlation between Q-markers and the overall anti-inammatory efcacy has been established. In the context of drug quality control, the comprehensive near­infrared spectroscopy (NIRS) methodology can effectively quantify diverse compo­nents and predict the overall biological activity. However, the prediction cannot be made solely by network toxicology or even bioinformatics, and additional tests are needed to conrm the ndings.
3.5 Conclusion
Due to their capacity to furnish insights into biological activity, clinical efcacy, and safety proles of pharmaceuticals, biotechnological methodologies hold com­parable importance to techniques reliant on physical and chemical analyses.
In certain situations, botanicals with similar chemical spectra may exhibit differ­ent biological activities when the bioactive constituents remain undetectable under specic analytical conditions. Conversely, botanicals with distinct chemical proles may demonstrate comparable bioactivity if the phytochemicals responsible for the variation are biologically inert. These are just some of the advantages and disadvan­tages of chemical technology and biotechnology. In the future, biotechnology should be involved in every stage of the drug quality control process, in addition to chemical and physical investigations. Currently, synthetic and natural products receive less use of bioanalytical technologies than biological medications. This could be as a result of the fact that most scientists working in the eld of pharma­ceutical analysis have backgrounds in chemistry. Pharmaceutical analysis today ignores the value of bioassays and their applications. As basic biology continues to advance and bioanalytical techniques improve as a result, biotechnology can become increasingly important in the overall quality control of both synthetic and natural pharmaceuticals.
3 Application ofBiotechnology inPharmaceutical Manufacturing Control
https://t.me/med1917
41
References
Ahmadi A, Danesh NM, Ramezani M, Alibolandia M, Lavaee P, Emrani AS etal (2019) A rapid
and simple ratiometric uorescent sensor for patulin detection based on a stabilized DNA
duplex probe containing less amount of aptamer-involved base pairs. Talanta 204:641–646 Ahmed S, Bui M-PN, Abbas A (2016) Paper-based chemical and biological sensors: engineering
aspects. Biosens Bioelectron 77:249–263 Andryukov BG, Lyapun IN, Matosova EV, Somova LM (2021) Biosensor technologies in medi-
cine: from detection of biochemical markers to research into molecular targets (review).
Sovrem Tekhnologii Med 12:70–83 Bhavadharini B, Kavimughil M, Malini B, Vallath A, Prajapati HK, Sunil CK (2022) Recent
advances in biosensors for detection of chemical contaminants in food—a review. Food Anal
Methods 15:1545–1564 Caglayan MO, U¨stu¨ndag Z (2020) Detection of zearalenone in an aptamer assay using attenu-
ated internal reection ellipsometry and its cereal sample applications. Food Chem Toxicol
136:111081 Ding G, Li B, Han Y, Liu A, Zhang J, Peng J etal (2016) A rapid integrated bioactivity evaluation
system based on near-infrared spectroscopy for quality control of Flos Chrysanthemi. J Pharm
Biomed Anal 131:391–399 Fraser K, Lane GA, Otter DE, Harrison SJ, Quek SY, Hemar Y etal (2013) Monitoring tea fermen-
tation/manufacturing by direct analysis in real time (DART) mass spectrometry. Food Chem
141:2060–2065 Gong X, Shao J, Guo S, Pan J, Fan X (2021) Determination of inhibitory activity of salvia milt-
iorrhiza extracts on xanthine oxidase with a paper-based analytical device. J Pharm Anal
11:603–610 Gu Z, Zhao M, Sheng Y, Bentolila LA, Tang Y (2011) Detection of mercury ion by infrared uo-
rescent protein and its hydrogel-based paper assay. Anal Chem 83:2324–2329 Guo S, Shao J, Gong X (2018) Paper-based analytical devices prepared with polycaprolactone
printing and their application in the activity determination of mulberry extracts. J Pharm
Biomed Anal 161:28–34 Guo S, Lin X, Wang Y, Gong X (2019) Fabrication of paper-based enzyme immobilized microar-
ray by 3D-printing technique for screening alpha-glucosidase inhibitors in mulberry leaves and
lotus leaves. Chin Med 14:13 He Y, Wua WB, Fu JZ (2015) Rapid fabrication of paper-based microuidic analytical devices
with desktop stereolithography 3D printer. RSC Adv 5:2694–2701 He D, Wu Z, Cui B, Jin Z, Xu E (2020) A uorometric method for aptamer-based simultaneous
determination of two kinds of the fusarium mycotoxins zearalenone and fumonisin B1 making
use of gold nanorods and upconversion nanoparticles. Mikrochim Acta 187:254 Jabbari S, Dabirmanesh B, Arab SS, Amanlou M, Daneshjou S, Gholami S etal (2017) A novel
enzyme based SPR-biosensor to detect bromocriptine as an ergoline derivative drug. Sensor
Actuator B Chem 240:519–527 Jiang M, Chen C, He J, Zhang H, Xu Z (2020) Fluorescence assay for three organophosphorus
pesticides in agricultural products based on magnetic-assisted uorescence labeling aptamer
probe. Food Chem 307:125534 Khan IM, Zhao S, Niazi S, Mohsin A, Shoaib M, Duan N etal (2018) Silver nanoclusters based
FRET aptasensor for sensitive and selective uorescent detection of T-2 toxin. Sensor Actuator
B Chem 277:328–335 Khan R, Sherazi TA, Catanante G, Rasheed S, Marty JL, Hayat A (2020) Switchable uorescence
sensor toward PAT via CA-MWCNTs quenched aptamer-tagged carboxy uorescein. Food
Chem 312:126048 Li ZH, Ai N, Yu LX, Qian ZZ, Cheng YY (2017) A multiple biomarker assay for quality assess-
ment of botanical drugs using a versatile microuidic chip. Sci Rep 7:12243
42
https://t.me/med1917
Li Z, Wang Y, Cheng Y (2019) Mass spectrometry-sensitive probes coupled with direct analysis
in real time for simultaneous sensing of chemical and biological properties of botanical drugs.
Anal Chem 91:9001–9009 Ma H, Li J, An M, Gao XM, Chang YX (2018) A powerful on line ABTS (þ)-CE-DAD method
to screen and quantify major antioxidants for quality control of Shuxuening injection. Sci
Rep 8:5441 Mahmoud M, Laufer S, Deigner HP (2019) Visual aptamer-based capillary assay for ethanolamine
using magnetic particles and strand displacement. Mikrochim Acta 186:690 Mitchell HT, Noxon IC, Chaplan CA, Carlton SJ, Liu CH, Ganaja KA etal (2015) Reagent pen-
cils: a new technique for solvent-free deposition of reagents onto paper-based microuidic
devices. Lab Chip 15:2213–2220 Ramakrishnan P, Loh WM, Gopinath SCB, Bonam SR, Fareez IM, Guad RM etal (2020) Selective
phytochemicals targeting pancreatic stellate cells as new anti-brotic agents for chronic pan-
creatitis and pancreatic cancer. Acta Pharm Sin B 10:399–413 Tao Y, Zhang Y, Wang Y, Chen Y (2013) Hollow ber based afnity selection combined with high
performance liquid chromatography-mass spectroscopy for rapid screening lipase inhibitors
from lotus leaf. Anal Chim Acta 785:75–81 Vigneshvar S, Sudhakumari CC, Senthilkumaran B, Prakash H (2016) Recent advances in biosen-
sor technology for potential applications—an overview. Front Bioeng Biotechnol 4:11 Wang H, Huang Y, Zhao X, Gong W, Wang Y, Cheng Y (2014) A novel aggregation-induced emis-
sion based uorescent probe for an angiotensin converting enzyme (ACE) assay and inhibitor
screening. Chem Commun 50:15075–15078 Wang H, Zhao Y, Bie S, Suo T, Jia G, Liu B etal (2019) Development of an electrochemical
biosensor for rapid and effective detection of pathogenic Escherichia coli in liquorice extract.
Appl Sci 9:295 Wang X, Chen X, Li J, Evans OB, Wang H, Yang X etal (2020) Thrombin-based discovery strat-
egy of bioactive-chemical quality marker combination for pollen of Typha orientalis by metab-
olomics coupled with chemometrics. Phytomedicine 75:153246 Wu S, Liu L, Duan N, Li Q, Zhou Y, Wang Z (2018) An aptamer-based lateral ow test strip for
rapid detection of zearalenone in corn samples. J Agric Food Chem 66:1949–1954 Xing KY, Peng J, Shan S, Liu D, Huang YN, Lai W (2020) Green enzyme linked immunosorbent
assay based on the single-stranded binding protein-assisted aptamer for the detection of myco-
toxin. Anal Chem 92:8422–8426 Zhang M, Wang Y, Yuan S, Sun X, Huo B, Bai J etal (2019) Competitive uorometric assay for the
food toxin T-2 by using DNA-modied silver nanoclusters, aptamer-modied magnetic beads,
and exponential isothermal amplication. Mikrochim Acta 186:219 Zhang Y, Lv X, Qu J, Zhang X, Zhang M, Gao H etal (2020) A systematic strategy for screening
therapeutic constituents of Schisandra chinensis (Turcz.) Baill inltrated blood-brain barrier
oriented in lesions using ethanol and water extracts: a novel perspective for exploring chemical
material basis of herb medicines. Acta Pharm Sin B 10:557–568 Zhang N, Li J, Liu B, Wang H, Zhang D, Li Z (2022) A facile “turn-on” uorescent aptasensor for
simultaneous detection of dual mycotoxins in traditional Chinese medicine based on graphene
oxide and FRET.Toxicon 206:42–50 Zhao YW, Wang HX, Jia GC, Li Z (2018) Application of aptamer-based biosensor for rapid detec-
tion of pathogenic Escherichia coli. Sensors (Basel) 18:2518 Zhong Y, Ru C, Wang S, Li Z, Cheng Y (2022) An online, non-destructive method for simul-
taneously detecting chemical, biological, and physical properties of herbal injections using
hyperspectral imaging with articial intelligence. Spectrochim Acta A Mol Biomol Spectrosc
264:120250 Zhu X, Rehman KU, Wang B, Shahzad M (2020) Modern soft-sensing modeling methods for
fermentation processes. Sensors 20:1771
G. Dey et al.
Chapter 4
https://t.me/med1917
Applications ofBiotechnology inPharmaceutical Product Analysis
MohdAslam, AnjaliRani, JavedKhan, BhaskaraNandPant, andGarimaPandey
Abstract The pharmaceutical sector is critical to supplying safe and effective phar-
maceuticals to people all around the world. Pharmaceutical product efcacy, safety, and quality are critical, needing stringent analytical methods to assure compliance with regulatory criteria. With its creative and adaptable approaches, biotechnology has revolutionized pharmaceutical product analysis by providing enhanced tools for a reliable and thorough evaluation. This chapter examines the various applications of biotechnology in pharmaceutical product analysis, focusing on how it has improved the identication, quantication, and characterization of active pharma­ceutical ingredients, contaminants, and formulation components. DNA sequencing, proteomics, genomics, and bioinformatics techniques have allowed for the exact determination of constituents as well as the evaluation of their sources. Overall, the introduction of biotechnology to pharmaceutical product analysis has considerably improved the pharmaceutical sector’s capacity to ensure reliability, safety, and func­tionality, instilling greater trust in healthcare practitioners and patients alike.
Keywords Biotechnology · Pharmaceutical analysis · Drug development · Biosensors
M. Aslam · A. Rani · J. Khan Department of Chemistry, SRM Institute of Science and Technology, Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh, India
Department of Chemistry, Atma Ram Sanatan Dharma College, University of Delhi, New Delhi, India
B. N. Pant Department of Chemistry, Atma Ram Sanatan Dharma College, University of Delhi, New Delhi, India
G. Pandey (*) Department of Chemistry, SRM Institute of Science and Technology, Delhi-NCR Campus, Modinagar, Ghaziabad, Uttar Pradesh, India
Ltd. 2024 S. Bose et al. (eds.), Concepts in Pharmaceutical Biotechnology and Drug Development, Interdisciplinary Biotechnological Advances,
https://doi.org/10.1007/978-981-97-1148-2_4
43© The Author(s), under exclusive license to Springer Nature Singapore Pte